|
시장보고서
상품코드
2058353
피부과 치료제 시장 : 용도별, 약물 종류별, 지역별Dermatological Therapeutic Market, By Application, By Drug Class, By Geography |
||||||
피부과 치료제 시장은 2026년에 547억 6,000만 달러로 추정되며, 2033년까지 941억 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 8%로 성장할 것으로 전망됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 547억 6,000만 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026년부터 2033년까지 예측 기간 CAGR: | 8.00% | 2033년 시장 규모 예측: | 941억 달러 |
피부과는 피부를 전문으로 다루는 의학의 한 분야입니다. 피부 질환은 사람들의 삶의 질에 심각한 영향을 미칩니다. 피부과 치료는 색소 침착, 피부 재생, 피부 탄력 개선, 노화에 따른 진피 및 혈관 병변 등 점점 늘어나는 증상의 치료에 활용되고 있습니다. 피부과 치료는 비침습적이며, 수술에 비해 시간이 덜 걸리고 비용 대비 효과가 뛰어나며, 더 나은 결과를 가져옵니다.
시장 역학
피부 질환의 증가, 고령 인구 증가, 안전하고 효과적인 치료법에 대한 수요 증가, 대중의 인식 제고, 연구 개발 활성화, 그리고 새로운 치료법의 빈번한 승인 및 출시가 전 세계 피부과 치료제 시장의 성장을 견인할 것으로 예상되는 주요 요인입니다.
예를 들어, 2022년 7월, 알미랄(Almirall)사는 오픈 이노베이션 플랫폼 'AlmirallShare'를 통해 피부과 연구 분야의 제휴를 구축하기 위한 제안을 모집하는 제7회 공모를 시작했다고 발표했습니다. 이는 피부 질환의 새로운 치료법이 될 수 있는, 전임상 또는 임상 개발 단계에 있는 자산과 관련된 새로운 협력 기회를 모색하는 것을 목적으로 합니다.
또한, 2021년 2월, 브리스톨-마이어스 스퀴브사는 중등도에서 중증의 일반성 건선 환자를 대상으로 한 경구용 선택적 티로신 키나아제 2(TYK2) 억제제인 데우클라바티닙의 치료 효과를 평가하는 두 건의 제3상 주요 임상시험에서 양호한 결과가 나왔다고 발표했습니다.
본 조사의 주요 특징
- 본 조사에서는 다양한 부문의 잠재적 수익 기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택하는 경쟁 전략에 관한 중요한 인사이트도 제공합니다.
- 본 보고서에서는 기업의 주요 정보, 제품 포트폴리오, 주요 성과, 재무 실적, 전략 등의 지표를 바탕으로 전 세계 피부과 치료제 시장의 주요 기업 개요을 소개하고 있습니다.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 피부과 치료제 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 피부과 치료제 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 피부과 치료제 시장 : 용도별, 2021-2033년
제5장 세계의 피부과 치료제 시장 : 약물 종류별, 2021-2033년
제6장 세계의 피부과 치료제 시장 : 지역별, 2021-2033년
제7장 경쟁 구도
제8장 섹션
KSM 26.06.19Dermatological Therapeutic Market is estimated to be valued at USD 54,760 Mn in 2026 and is expected to reach USD 94,100 Mn by 2033, growing at a compound annual growth rate (CAGR) of 8% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 54,760 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 8.00% | 2033 Value Projection: | USD 94,100 Mn |
Dermatology is an area of medicine dealing specifically with the skin. Skin diseases have a serious impact on people's quality of life. Dermatology therapeutics are used to treat increasing cases of pigmented skin, skin resurfacing, skin tightening, and age-related dermal/vascular lesions, among others. Dermatology treatments are non-invasive require less time, cost-effective, and offer better results as compared to surgeries.
Market Dynamics
Rise in burden of dermatology diseases, growing geriatric population, rise in demand for safe and effective therapeutics, rise in awareness among people, increase in research and development, and frequent approvals and launches of novel therapeutics are major factors expected to drive growth of the global dermatological therapeutic market.
For instance, in July 2022, Almirall announced the launch of its 7th call through AlmirallShare, its open innovation platform, for proposals to establish collaborations in dermatological research. The aim of this is to find new partnership opportunities for assets in preclinical or clinical development stages that can become new treatments for skin diseases.
Moreover, in February 2021, Bristol Myers Squibb announced positive results from two pivotal Phase 3 trials evaluating deucravacitinib, an oral, selective tyrosine kinase 2 (TYK2) inhibitor, for the treatment of patients with moderate to severe plaque psoriasis.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global dermatological therapeutic market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Leo Pharma, Pfizer Inc., Novartis AG, Johnson & Johnson, GlaxoSmithKline PLC, Galderma, Amgen Inc., Almirall, S.A., XBiotech USA Inc., AbbVie Inc, and Bausch Health Companies Inc., among others.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global dermatological therapeutic market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global dermatological therapeutic market.
Market Segmentation
- By Application (Revenue, USD Mn, 2021-2033)
- Alopecia
- Herpes
- Psoriasis
- Rosacea
- Atopic Dermatitis
- Acne Vulgaris
- Vitiligo
- Hidradenitis
- Other Applications
- By Drug Class (Revenue, USD Mn, 2021-2033)
- Anti-infectives
- Corticosteroids
- Calcineurin Inhibitors
- Retinoids
- Other Drug Classes
- By Region (Revenue, USD Mn, 2021-2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Key Players
- LEO Pharma
- Pfizer Inc.
- Novartis AG
- Johnson & Johnson
- GlaxoSmithKline PLC
- Galderma
- Amgen Inc.
- Almirall S.A.
- XBiotech USA Inc.
- AbbVie Inc.
- Bausch Health Companies Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Application
- Market Snapshot, By Drug Class
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Product Approval
- Collaboration/Merge/Acquisition
- Regulatory Landscape
- PEST Analysis
- Porter's Five Forces Analysis
- Epidemiology
- Robust Pipeline Analysis
4. Global Dermatological Therapeutic Market, By Application, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
- Alopecia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Herpes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Psoriasis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Rosacea
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Atopic Dermatitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Acne Vulgaris
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Vitiligo
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Hidradenitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Other Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global Dermatological Therapeutic Market, By Drug Class, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Anti-infectives
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Corticosteroids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Calcineurin Inhibitors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Retinoids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Other Drug Classes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global Dermatological Therapeutic Market, By Region, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
- North Africa
- Central Africa
- South Africa
7. Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Company Profile
- LEO Pharma
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Johnson & Johnson
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- GlaxoSmithKline PLC
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Galderma
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Amgen Inc.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Almirall S.A.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- XBiotech USA Inc.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- AbbVie Inc.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Bausch Health Companies Inc.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Analyst Views
- LEO Pharma
8. Section
- References
- Research Methodology
- About Us
